gamma-aminobutyric acid has been researched along with Myoclonic Jerk in 67 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a patient with acute renal failure who developed hearing loss, myoclonus, and confusion with hallucinations in the presence of elevated gabapentin concentrations." | 7.74 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| " injection of bicuculline (4, 6 or 8 mg/kg) and were immediately tested for latency to initial myoclonic jerk and clonus." | 7.67 | Coping and seizure susceptibility: control over shock protects against bicuculline-induced seizures. ( Alpern, HP; Drugan, RC; Maier, SF; McIntyre, TD, 1985) |
| "Vigabatrin was most effective in cryptogenic and symptomatic partial seizures (39% and 43%, respectively), and in infantile spasms (25%)." | 6.68 | Vigabatrin as add-on therapy in children and adolescents with refractory epilepsy: an open trial. ( Coppola, G; Pascotto, A; Terraciano, AM, 1997) |
| "We report a patient with acute renal failure who developed hearing loss, myoclonus, and confusion with hallucinations in the presence of elevated gabapentin concentrations." | 5.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "Gabapentin is an antiepileptic agent indicated for use as an adjunct therapy in partial seizures and postherpetic neuralgia but is also prescribed for the treatment of diabetic peripheral neuropathy." | 5.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "The patient's symptoms (hearing loss, myoclonus, and confusion) improved after 1 session of hemodialysis (approximately 10 hours following admission) and had resolved at the time of discharge (4 days later)." | 5.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "The latency to clonic convulsion was dramatically affected by prior shock treatment, and the direction of this change depended upon the escapability/inescapability of the shock." | 5.27 | Coping and seizure susceptibility: control over shock protects against bicuculline-induced seizures. ( Alpern, HP; Drugan, RC; Maier, SF; McIntyre, TD, 1985) |
| "We report a patient with acute renal failure who developed hearing loss, myoclonus, and confusion with hallucinations in the presence of elevated gabapentin concentrations." | 3.74 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "To report on the occurrence of myoclonus in patients receiving gabapentin (GBP) for the treatment of epilepsy." | 3.70 | Myoclonus associated with the use of gabapentin. ( Asconapé, J; DellaBadia, J; Diedrich, A, 2000) |
| "We report two cases of unusual movement disorders associated with the use of gabapentin (GBP) in patients being treated for epilepsy who were otherwise neurologically intact." | 3.69 | Movement disorders associated with the use of gabapentin. ( Krahn, LE; Reeves, AL; Sharbrough, FW; So, EL, 1996) |
| " injection of bicuculline (4, 6 or 8 mg/kg) and were immediately tested for latency to initial myoclonic jerk and clonus." | 3.67 | Coping and seizure susceptibility: control over shock protects against bicuculline-induced seizures. ( Alpern, HP; Drugan, RC; Maier, SF; McIntyre, TD, 1985) |
| "A case of post-anoxic action myoclonus is reported in which a very good control of the myoclonic jerks was achieved with levodopa, gaba and bacoflen, while the antiepileptic drugs did not seem to be useful." | 3.66 | Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and GABAergic drugs. ( Coletti, A; Mandelli, A; Minoli, G; Tredici, G, 1980) |
| "In the other cases, myoclonus was only subtle and did not significantly interfere with daily activities, so that a dose reduction of PGB was not considered necessary." | 2.70 | Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. ( Feuerstein, TJ; Huppertz, HJ; Schulze-Bonhage, A, 2001) |
| "All patients had medically refractory focal epilepsy and received other antiepileptic drugs (AEDs) besides the study medication." | 2.70 | Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. ( Feuerstein, TJ; Huppertz, HJ; Schulze-Bonhage, A, 2001) |
| "To report on the occurrence of myoclonus in patients receiving pregabalin (PGB) for the treatment of focal epilepsy." | 2.70 | Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. ( Feuerstein, TJ; Huppertz, HJ; Schulze-Bonhage, A, 2001) |
| "Vigabatrin was most effective in cryptogenic and symptomatic partial seizures (39% and 43%, respectively), and in infantile spasms (25%)." | 2.68 | Vigabatrin as add-on therapy in children and adolescents with refractory epilepsy: an open trial. ( Coppola, G; Pascotto, A; Terraciano, AM, 1997) |
| "Negative myoclonus is a jerky, brief, and sudden interruption of voluntary muscle contraction." | 2.55 | Negative myoclonus induced by gabapentin and pregabalin: A case series and systematic literature review. ( Jung, JM; Kim, JB; Kwon, DY; Lee, EJ; Park, MH, 2017) |
| "We collected the patients with negative myoclonus who were referred to the department of neurology at a university-affiliated hospital and selected pregabalin- or gabapentin-induced negative myoclonus." | 2.55 | Negative myoclonus induced by gabapentin and pregabalin: A case series and systematic literature review. ( Jung, JM; Kim, JB; Kwon, DY; Lee, EJ; Park, MH, 2017) |
| "A total of 77 patients with negative myoclonus were reviewed." | 2.55 | Negative myoclonus induced by gabapentin and pregabalin: A case series and systematic literature review. ( Jung, JM; Kim, JB; Kwon, DY; Lee, EJ; Park, MH, 2017) |
| "So-called symptomatic myoclonus is the type that occurs secondary to an identifiable disorder; it is usually accompanied by other neurological signs and is the most frequent kind." | 2.45 | [Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment]. ( Erro, ME; Navarro, MC, 2009) |
| "Epileptic myoclonus is that which forms part of an epileptic syndrome with a genetic or idiopathic cause, or that is due to static encephalopathy." | 2.45 | [Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment]. ( Erro, ME; Navarro, MC, 2009) |
| " Their beneficial effects decline with chronic administration because of drug tolerance, and the theoretical basis for BDZ responses remains unclear." | 2.38 | Myoclonus: analysis of monoamine, GABA, and other systems. ( Snodgrass, SR, 1990) |
| "Not until patients with myoclonus and major functional disability were reported in the 1960s was attention given to understanding its basis and pharmacotherapy." | 2.38 | Myoclonus: analysis of monoamine, GABA, and other systems. ( Snodgrass, SR, 1990) |
| "Myoclonus is a clinical term meaning a quick involuntary jerk, seen in normal subjects under certain circumstances, including sleep, and in certain disease states." | 2.38 | Myoclonus: analysis of monoamine, GABA, and other systems. ( Snodgrass, SR, 1990) |
| "The diagnosis of myoclonus was more difficult than those of epilepsy, because the clarification of pathogenesis and definition of diagnosis was lacked." | 2.38 | [Diagnosis and therapy of epilepsy and myoclonus]. ( Okamoto, Y; Ota, K, 1993) |
| "Clonazepam is a potent anticonvulsant 1,4-benzodiazepine that controls some types of myoclonus." | 2.37 | Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT. ( Jenner, P; Marsden, CD; Pratt, JA, 1986) |
| " With 2-L exchanges every 2 hours, we document an apparent elimination half-life of 41." | 1.46 | Treatment of Gabapentin Toxicity With Peritoneal Dialysis: Assessment of Gabapentin Clearance. ( Edwards, JC; Ibrahim, H; Oman, Z; Schuelke, M, 2017) |
| "Acquired pendular nystagmus (APN) occurs with multiple sclerosis (MS) and oculopalatal tremor (OPT); distinct features of the nystagmus have led to the development of separate models for their pathogenesis." | 1.37 | Pharmacological tests of hypotheses for acquired pendular nystagmus. ( Leigh, RJ; Optican, LM; Shaikh, AG; Thurtell, MJ, 2011) |
| "We report a patient with acute renal failure who developed hearing loss, myoclonus, and confusion with hallucinations in the presence of elevated gabapentin concentrations." | 1.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "The patient's symptoms (hearing loss, myoclonus, and confusion) improved after 1 session of hemodialysis (approximately 10 hours following admission) and had resolved at the time of discharge (4 days later)." | 1.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "Furthermore, the threshold of seizures induced by pentylenetetrazol was significantly reduced in both heterozygous and null mutants." | 1.35 | Efhc1 deficiency causes spontaneous myoclonus and increased seizure susceptibility. ( Delgado-Escueta, AV; Hensch, TK; Hirota, Y; Inoue, I; Itohara, S; Jiang, B; Miyamoto, H; Nakahari, T; Saido, TC; Sawamoto, K; Suemoto, T; Suzuki, T; Tsumoto, T; Yamakawa, K, 2009) |
| "We found 3 cases (1." | 1.35 | [Development or worsening of myoclonus associated with gabapentin therapy]. ( Ikeda, H; Inoue, Y; Koide, Y, 2009) |
| "Gabapentin is an antiepileptic agent indicated for use as an adjunct therapy in partial seizures and postherpetic neuralgia but is also prescribed for the treatment of diabetic peripheral neuropathy." | 1.35 | A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure. ( Holt, SR; Pierce, DA; Reeves-Daniel, A, 2008) |
| "All the patients had repetitive myoclonus of all limbs, impairing gait in 14 patients." | 1.34 | Whole-body tremulousness: isolated generalized polymyoclonus. ( Ahlskog, JE; Bower, JH; Glass, GA; Josephs, KA; Lennon, VA; McKeon, A; Pittock, SJ, 2007) |
| "Treatment of myoclonus and underlying causes." | 1.34 | Whole-body tremulousness: isolated generalized polymyoclonus. ( Ahlskog, JE; Bower, JH; Glass, GA; Josephs, KA; Lennon, VA; McKeon, A; Pittock, SJ, 2007) |
| "To describe isolated generalized polymyoclonus and the outcomes of etiologic evaluations at the time of diagnosis." | 1.34 | Whole-body tremulousness: isolated generalized polymyoclonus. ( Ahlskog, JE; Bower, JH; Glass, GA; Josephs, KA; Lennon, VA; McKeon, A; Pittock, SJ, 2007) |
| "Lingual myoclonus is a poorly understood disorder that may occur in isolation or combined with palatal myoclonus." | 1.34 | New device to control combined lingual and palatal myoclonus. ( Boon, AJ; de Gier, HH; Mondria, T, 2007) |
| "Acquired generalized repetitive myoclonus may be mistaken for tremor." | 1.34 | Whole-body tremulousness: isolated generalized polymyoclonus. ( Ahlskog, JE; Bower, JH; Glass, GA; Josephs, KA; Lennon, VA; McKeon, A; Pittock, SJ, 2007) |
| "Distinguishing myoclonus has etiologic and therapeutic implications." | 1.34 | Whole-body tremulousness: isolated generalized polymyoclonus. ( Ahlskog, JE; Bower, JH; Glass, GA; Josephs, KA; Lennon, VA; McKeon, A; Pittock, SJ, 2007) |
| "GBP increases the risk of myoclonus in ESRD." | 1.33 | Gabapentin-induced myoclonus in end-stage renal disease. ( Bell, WL; Glenn, DG; O'Donovan, CA; Zhang, C, 2005) |
| "Myoclonus was characterized as multifocal, involving all extremities in the three patients." | 1.33 | Gabapentin-induced myoclonus in end-stage renal disease. ( Bell, WL; Glenn, DG; O'Donovan, CA; Zhang, C, 2005) |
| "Three of 71 patients had myoclonus with GBP doses ranging from 9 mg/kg to 20 mg/kg and within 4 months of treatment onset." | 1.33 | Gabapentin-induced myoclonus in end-stage renal disease. ( Bell, WL; Glenn, DG; O'Donovan, CA; Zhang, C, 2005) |
| "GBP-associated myoclonus appears to be relatively frequent." | 1.31 | Myoclonus associated with the use of gabapentin. ( Asconapé, J; DellaBadia, J; Diedrich, A, 2000) |
| "To report on the occurrence of myoclonus in patients receiving gabapentin (GBP) for the treatment of epilepsy." | 1.31 | Myoclonus associated with the use of gabapentin. ( Asconapé, J; DellaBadia, J; Diedrich, A, 2000) |
| "We found 13 cases of myoclonus." | 1.31 | Myoclonus associated with the use of gabapentin. ( Asconapé, J; DellaBadia, J; Diedrich, A, 2000) |
| "A patient with adult onset Huntington's disease (HD) and prominent action myoclonus is described." | 1.29 | Adult onset myoclonic Huntington's disease. ( Binelli, S; Carella, F; Ciano, C; Girotti, F; Oliva, D; Scaioli, V, 1993) |
| "We report the appearance of multifocal myoclonus in two adult patients treated with vigabatrin as an add-on drug for complex partial seizures." | 1.29 | Vigabatrin and multifocal myoclonus in adults with partial seizures. ( Neufeld, MY; Vishnevska, S, 1995) |
| "Gabapentin dose-dependently attenuated myoclonus in posthypoxic rats for more than 3 h." | 1.29 | Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus. ( Kanthasamy, AG; Truong, DD; Vu, TQ; Yun, RJ, 1996) |
| "Nevertheless, as this myoclonus is blocked by physostigmine, the effect of benzodiazepines is probably due to their indirect action on the cholinergic system." | 1.28 | Drugs influencing the GABAergic neurotransmission have no effect on the non-epileptic myoclonus of baboons. ( Barthuel, P; Ménini, C; Rektor, I; Silva-Barrat, C, 1991) |
| "Pretreatment with 5-hydroxytryptophan (5-HTP), a precursor of 5-HT, antagonised while pretreatment with p-chlorophenylalanine (PCPA), a 5-HT depletor, potentiated the myoclonus induced by picrotoxin, a GABA antagonist." | 1.28 | A functional interaction between GABA and 5-HT in inhibiting picrotoxin-induced myoclonus in rats. ( Krishnamoorthy, MS; Paul, V, 1990) |
| "Pretreatment with aminooxyacetic acid (AOAA), a GABA transaminase inhibitor, antagonised picrotoxin-induced myoclonus." | 1.28 | A functional interaction between GABA and 5-HT in inhibiting picrotoxin-induced myoclonus in rats. ( Krishnamoorthy, MS; Paul, V, 1990) |
| "Inherited congenital myoclonus (ICM) of Poll Hereford cattle is a neurological disease in which there are severe alterations in spinal cord glycine-mediated neurotransmission." | 1.28 | Increased gamma-aminobutyric acid receptor function in the cerebral cortex of myoclonic calves with an hereditary deficit in glycine/strychnine receptors. ( Dodd, PR; Gundlach, AL; Harper, PA; Johnston, GA; Lummis, SC, 1990) |
| "Ro 15-1788 completely blocked type B myoclonus without decreasing the level of vigilance in the two types of baboons, and reversed the antiepileptic action of the BZs in the photosensitive ones, permitting the reappearance of myoclonus following EEG paroxysmal discharges (type A)." | 1.27 | Differential effects of the benzodiazepine antagonist Ro 15-1788 on two types of myoclonus in baboon Papio papio. ( Bryere, P; Kaijima, M; Naquet, R; Valin, A, 1983) |
| "The latency to clonic convulsion was dramatically affected by prior shock treatment, and the direction of this change depended upon the escapability/inescapability of the shock." | 1.27 | Coping and seizure susceptibility: control over shock protects against bicuculline-induced seizures. ( Alpern, HP; Drugan, RC; Maier, SF; McIntyre, TD, 1985) |
| "No protection against seizures was seen after THIP, 1-4 mg/kg, intraperitoneally in mice." | 1.26 | Effects of the bicyclic GABA agonist, THIP, on myoclonic and seizure responses in mice and baboons with reflex epilepsy. ( Horton, R; Meldrum, B, 1980) |
| "A case of post-anoxic action myoclonus is reported in which a very good control of the myoclonic jerks was achieved with levodopa, gaba and bacoflen, while the antiepileptic drugs did not seem to be useful." | 1.26 | Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and GABAergic drugs. ( Coletti, A; Mandelli, A; Minoli, G; Tredici, G, 1980) |
| " Prevention is easy if treatment is gradually rather than abruptly withdrawn in all patients who receive the compound in high dosage for more than one month." | 1.26 | [Benzodiazepine physical dependence. 6 cases (author's transl)]. ( Bismuth, C; Dally, S; Lagier, G; Le Bellec, M, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (38.81) | 18.7374 |
| 1990's | 15 (22.39) | 18.2507 |
| 2000's | 18 (26.87) | 29.6817 |
| 2010's | 8 (11.94) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibrahim, H | 1 |
| Oman, Z | 1 |
| Schuelke, M | 1 |
| Edwards, JC | 1 |
| Amin, F | 1 |
| Dar, AH | 1 |
| Osama, K | 1 |
| Khan, F | 1 |
| Mitha, R | 1 |
| Tharwani, A | 1 |
| Haider, G | 1 |
| Chand, P | 1 |
| Arain, FM | 1 |
| Kim, JB | 1 |
| Jung, JM | 1 |
| Park, MH | 1 |
| Lee, EJ | 1 |
| Kwon, DY | 1 |
| Shea, YF | 1 |
| Mok, MM | 1 |
| Chang, RS | 1 |
| Ege, F | 1 |
| Koçak, Y | 1 |
| Titiz, AP | 1 |
| Oztürk, SM | 1 |
| Oztürk, S | 1 |
| Ozbakir, S | 1 |
| Pierce, DA | 1 |
| Holt, SR | 1 |
| Reeves-Daniel, A | 1 |
| Suzuki, T | 1 |
| Miyamoto, H | 1 |
| Nakahari, T | 1 |
| Inoue, I | 1 |
| Suemoto, T | 1 |
| Jiang, B | 1 |
| Hirota, Y | 1 |
| Itohara, S | 1 |
| Saido, TC | 1 |
| Tsumoto, T | 1 |
| Sawamoto, K | 1 |
| Hensch, TK | 1 |
| Delgado-Escueta, AV | 1 |
| Yamakawa, K | 1 |
| Erro, ME | 1 |
| Navarro, MC | 1 |
| Koide, Y | 1 |
| Ikeda, H | 1 |
| Inoue, Y | 1 |
| Healy, DG | 1 |
| Ingle, GT | 1 |
| Brown, P | 1 |
| Lucey, BP | 1 |
| Noetzel, MJ | 1 |
| Duntley, SP | 1 |
| Prieto-Pérez, L | 1 |
| Montastruc, J | 1 |
| García-Ruiz, PJ | 1 |
| Shaikh, AG | 1 |
| Thurtell, MJ | 1 |
| Optican, LM | 1 |
| Leigh, RJ | 1 |
| Shimizu, T | 1 |
| Yoshida, T | 1 |
| Kitamura, K | 1 |
| Hamada, O | 1 |
| Tschampa, HJ | 1 |
| Herms, JW | 1 |
| Schulz-Schaeffer, WJ | 1 |
| Maruschak, B | 1 |
| Windl, O | 1 |
| Jastrow, U | 1 |
| Zerr, I | 1 |
| Steinhoff, BJ | 1 |
| Poser, S | 1 |
| Kretzschmar, HA | 1 |
| Gazulla Abío, J | 1 |
| Feijóo de Freixo, M | 1 |
| Val Adán, P | 1 |
| Benavente Aguilar, I | 1 |
| Scullin, P | 1 |
| Sheahan, P | 1 |
| Sheila, K | 1 |
| Zhang, C | 1 |
| Glenn, DG | 1 |
| Bell, WL | 1 |
| O'Donovan, CA | 1 |
| Holtkamp, M | 1 |
| Halle, A | 1 |
| Meierkord, H | 1 |
| Masuhr, F | 1 |
| Hess, CW | 1 |
| Saunders-Pullman, R | 1 |
| Mondria, T | 1 |
| de Gier, HH | 1 |
| Boon, AJ | 1 |
| McKeon, A | 1 |
| Pittock, SJ | 1 |
| Glass, GA | 1 |
| Josephs, KA | 1 |
| Bower, JH | 1 |
| Lennon, VA | 1 |
| Ahlskog, JE | 1 |
| Bismuth, C | 1 |
| Le Bellec, M | 1 |
| Dally, S | 1 |
| Lagier, G | 1 |
| Buckett, WR | 1 |
| Valin, A | 1 |
| Kaijima, M | 1 |
| Bryere, P | 1 |
| Naquet, R | 3 |
| Coletti, A | 1 |
| Mandelli, A | 1 |
| Minoli, G | 1 |
| Tredici, G | 1 |
| Ando, K | 1 |
| File, SE | 1 |
| Simmonds, MA | 1 |
| Meldrum, B | 1 |
| Horton, R | 1 |
| Menon, MK | 1 |
| Iakimovskiĭ, AF | 1 |
| Okamoto, Y | 1 |
| Ota, K | 1 |
| Carella, F | 1 |
| Scaioli, V | 1 |
| Ciano, C | 1 |
| Binelli, S | 1 |
| Oliva, D | 1 |
| Girotti, F | 1 |
| Neufeld, MY | 1 |
| Vishnevska, S | 1 |
| Kanthasamy, AG | 1 |
| Vu, TQ | 1 |
| Yun, RJ | 1 |
| Truong, DD | 1 |
| Reeves, AL | 1 |
| So, EL | 1 |
| Sharbrough, FW | 1 |
| Krahn, LE | 1 |
| Brailowsky, S | 1 |
| Scotti, AL | 1 |
| Bollag, O | 1 |
| Kalt, G | 1 |
| Nitsch, C | 1 |
| Coppola, G | 1 |
| Terraciano, AM | 1 |
| Pascotto, A | 1 |
| Kriem, B | 1 |
| Cagniard, B | 1 |
| Bouquet, C | 1 |
| Rostain, JC | 2 |
| Abraini, JH | 1 |
| de Toffol, B | 1 |
| Hommet, C | 1 |
| Corcia, P | 1 |
| Autret, A | 1 |
| Asconapé, J | 1 |
| Diedrich, A | 1 |
| DellaBadia, J | 1 |
| Mercadante, S | 1 |
| Villari, P | 1 |
| Fulfaro, F | 1 |
| Huppertz, HJ | 1 |
| Feuerstein, TJ | 1 |
| Schulze-Bonhage, A | 1 |
| Matsumoto, RR | 1 |
| Meldrum, BS | 5 |
| Tarsy, D | 2 |
| Pycock, CJ | 1 |
| Marsden, CD | 3 |
| Pycock, C | 1 |
| Catier, J | 1 |
| Menini, C | 2 |
| Rektor, I | 1 |
| Silva-Barrat, C | 1 |
| Barthuel, P | 1 |
| Paul, V | 1 |
| Krishnamoorthy, MS | 1 |
| Lummis, SC | 1 |
| Gundlach, AL | 1 |
| Johnston, GA | 1 |
| Harper, PA | 1 |
| Dodd, PR | 1 |
| Snodgrass, SR | 2 |
| Van Woert, MH | 3 |
| Rosenbaum, D | 1 |
| Chung, EY | 3 |
| Jenner, P | 1 |
| Pratt, JA | 1 |
| Pranzatelli, MR | 1 |
| Chapman, AG | 1 |
| Wardley-Smith, B | 1 |
| Forni, C | 1 |
| Halsey, MJ | 1 |
| Bo, P | 1 |
| Camana, C | 1 |
| Curti, M | 1 |
| Fussi, F | 1 |
| Giorgetti, A | 1 |
| Savoldi, F | 1 |
| Mondrup, K | 1 |
| Dupont, E | 1 |
| Braendgaard, H | 1 |
| Angel, A | 1 |
| Drugan, RC | 1 |
| McIntyre, TD | 1 |
| Alpern, HP | 1 |
| Maier, SF | 1 |
| Soyka, D | 1 |
13 reviews available for gamma-aminobutyric acid and Myoclonic Jerk
| Article | Year |
|---|---|
Negative myoclonus induced by gabapentin and pregabalin: A case series and systematic literature review.
Topics: Aged; Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma- | 2017 |
[Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment].
Topics: 5-Hydroxytryptophan; Anticonvulsants; Antidepressive Agents, Second-Generation; Diagnosis, Different | 2009 |
Movement disorders and alcohol misuse.
Topics: Adjuvants, Anesthesia; Alcohol Drinking; Brain; Comorbidity; Dystonic Disorders; Essential Tremor; E | 2006 |
[Biogenic amines to the pathophysiology of involuntary movements and cerebellar ataxia (author's transl)].
Topics: Adolescent; Biogenic Amines; Brain; Cerebellar Ataxia; Child; Child, Preschool; Dystonia; gamma-Amin | 1981 |
[Diagnosis and therapy of epilepsy and myoclonus].
Topics: Acetates; Amines; Cerebral Cortex; Cyclohexanecarboxylic Acids; Electrophysiology; Epilepsy; Gabapen | 1993 |
GABA and epilepsy in the photosensitive baboon Papio papio.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy; GABA-A Receptor Agonists; GABA-A Recepto | 1996 |
[Anticonvulsants can aggravate idiopathic generalized epilepsy].
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Epilepsies, Myoclonic; Epilepsy, Ab | 1998 |
Involvement of gamma-aminobutyric acid in myoclonus.
Topics: Animals; Brain; Disease Models, Animal; GABA Antagonists; gamma-Aminobutyric Acid; Humans; Myoclonus | 2002 |
Myoclonus: analysis of monoamine, GABA, and other systems.
Topics: Animals; Biogenic Amines; Epilepsy; gamma-Aminobutyric Acid; Glycine; Humans; Myoclonus; Neurons; Re | 1990 |
Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT.
Topics: 5-Hydroxytryptophan; Animals; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Brain; Clonazepam | 1986 |
Drugs acting on amino acid neurotransmitters.
Topics: Acoustic Stimulation; Amino Acids; Animals; Chemical Phenomena; Chemistry; Diazepam; Electrophysiolo | 1986 |
The pharmacology of myoclonus.
Topics: 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Animals; Anticonvulsants; Benzodiazepines; Brain; | 1985 |
Valproate and myoclonus.
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Aspartic Acid; Clonazepam; DDT; Disease Models, Animal; F | 1986 |
2 trials available for gamma-aminobutyric acid and Myoclonic Jerk
| Article | Year |
|---|---|
Vigabatrin as add-on therapy in children and adolescents with refractory epilepsy: an open trial.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combinat | 1997 |
Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin.
Topics: Acetates; Adult; Amines; Anticonvulsants; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Dos | 2001 |
52 other studies available for gamma-aminobutyric acid and Myoclonic Jerk
| Article | Year |
|---|---|
Treatment of Gabapentin Toxicity With Peritoneal Dialysis: Assessment of Gabapentin Clearance.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Diabetic Nephropathies; Diabetic Neuropathies; Fema | 2017 |
A species dependent response to the pro-epileptic drug pentylentetrazole in birds.
Topics: Animals; Convulsants; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamic Acid; Immu | 2017 |
Gabapentin-induced myoclonus in an elderly with end-stage renal failure.
Topics: Aged; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobuty | 2014 |
Gabapentin-Induced myoclonus: case report.
Topics: Aged, 80 and over; Amines; Antiparkinson Agents; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Amin | 2008 |
A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure.
Topics: Acute Kidney Injury; Amines; Anticonvulsants; Anuria; Comorbidity; Cyclohexanecarboxylic Acids; Diab | 2008 |
Efhc1 deficiency causes spontaneous myoclonus and increased seizure susceptibility.
Topics: Animals; Calcium-Binding Proteins; Cerebral Ventricles; Cilia; Convulsants; Dentate Gyrus; gamma-Ami | 2009 |
[Development or worsening of myoclonus associated with gabapentin therapy].
Topics: Adult; Amines; Anticonvulsants; Contraindications; Cyclohexanecarboxylic Acids; Epilepsy, Tonic-Clon | 2009 |
Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure.
Topics: Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; K | 2009 |
Paroxysmal arousals and myoclonic movements associated with interictal epileptiform discharges in NREM and REM sleep.
Topics: Adolescent; Amines; Antiparkinson Agents; Arousal; Chromosome Disorders; Chromosome Inversion; Chrom | 2011 |
[Myoclonias secondary to gabapentin in a patient with chronic renal failure].
Topics: Aged; Amines; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Kidney Failu | 2011 |
Pharmacological tests of hypotheses for acquired pendular nystagmus.
Topics: Amines; Baclofen; Cerebellar Cortex; Cyclohexanecarboxylic Acids; Eye Movements; Gabapentin; gamma-A | 2011 |
Disturbance of consciousness and involuntary movements caused by pregabalin.
Topics: Aged, 80 and over; Analgesics; Consciousness Disorders; Diazepam; GABA Modulators; gamma-Aminobutyri | 2012 |
Clinical findings in sporadic Creutzfeldt-Jakob disease correlate with thalamic pathology.
Topics: Action Potentials; Adult; Aged; Creutzfeldt-Jakob Syndrome; Electroencephalography; Female; gamma-Am | 2002 |
[Clinical and neurochemical aspects of diaphragmatic myoclonus].
Topics: Acetates; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Diaphragm; Female; GABA Agoni | 2003 |
Myoclonic jerks associated with gabapentin.
Topics: Acetates; Adult; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobut | 2003 |
Gabapentin-induced myoclonus in end-stage renal disease.
Topics: Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric | 2005 |
Gabapentin-induced severe myoclonus in a patient with impaired renal function.
Topics: Aged; Amines; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Kidney Disea | 2006 |
New device to control combined lingual and palatal myoclonus.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Clonazepam; Cyclohexanecarboxylic Acids; Eye Movement | 2007 |
Whole-body tremulousness: isolated generalized polymyoclonus.
Topics: Adult; Aged; Amines; Anticonvulsants; Autoimmunity; Breast Neoplasms; Clonazepam; Cyclohexanecarboxy | 2007 |
[Benzodiazepine physical dependence. 6 cases (author's transl)].
Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Dreams; Electroencephalography; Female; gamma-Ami | 1980 |
Intravenous bicuculline test in mice: characterization with GABAergic drugs.
Topics: 4-Aminobutyrate Transaminase; Animals; Anti-Anxiety Agents; Benzodiazepines; Bicuculline; Female; ga | 1981 |
Differential effects of the benzodiazepine antagonist Ro 15-1788 on two types of myoclonus in baboon Papio papio.
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepinones; Flumazenil; g | 1983 |
Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and GABAergic drugs.
Topics: Anticonvulsants; Baclofen; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Hypox | 1980 |
Interactions of two phenylquinolines with picrotoxin and benzodiazepines in vivo and in vitro.
Topics: Animals; Anticonvulsants; Benzodiazepines; Drug Interactions; gamma-Aminobutyric Acid; Male; Mice; M | 1984 |
Effects of the bicyclic GABA agonist, THIP, on myoclonic and seizure responses in mice and baboons with reflex epilepsy.
Topics: Animals; Anticonvulsants; Electroencephalography; gamma-Aminobutyric Acid; Haplorhini; Isoxazoles; M | 1980 |
Paradoxical blockade of a muscimol response by THIP, a GABA agonist and also by GABA-transaminase inhibitors.
Topics: 4-Aminobutyrate Transaminase; Animals; gamma-Aminobutyric Acid; Isoxazoles; Male; Mice; Muscimol; My | 1981 |
[Myoclonic hyperkinesis induced by repeated administration of picrotoxin into rat neostriatum].
Topics: Animals; Avoidance Learning; gamma-Aminobutyric Acid; Generalization, Stimulus; Hyperkinesis; Male; | 1993 |
Adult onset myoclonic Huntington's disease.
Topics: Adult; Atrophy; Cerebral Cortex; Corpus Striatum; Electric Stimulation; Electroencephalography; Elec | 1993 |
Vigabatrin and multifocal myoclonus in adults with partial seizures.
Topics: Adult; Anticonvulsants; Electroencephalography; Epilepsy, Complex Partial; Female; gamma-Aminobutyri | 1995 |
Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus.
Topics: Acetates; Acoustic Stimulation; Amines; Animals; Anticonvulsants; Cyclohexanecarboxylic Acids; DDT; | 1996 |
Movement disorders associated with the use of gabapentin.
Topics: Acetates; Adult; Amines; Anticonvulsants; Benzodiazepines; Cyclohexanecarboxylic Acids; Dyskinesia, | 1996 |
Loss of perikaryal parvalbumin immunoreactivity from surviving GABAergic neurons in the CA1 field of epileptic gerbils.
Topics: Animals; Arousal; Epilepsy; Epilepsy, Tonic-Clonic; gamma-Aminobutyric Acid; Gerbillinae; Hippocampu | 1997 |
Modulation by GABA transmission in the substantia nigra compacta and reticulata of locomotor activity in rats exposed to high pressure.
Topics: Animals; Baclofen; GABA Agonists; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Helium | 1998 |
Myoclonus associated with the use of gabapentin.
Topics: Acetates; Adolescent; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Dose-Response Rel | 2000 |
Gabapentin for opiod-related myoclonus in cancer patients.
Topics: Acetates; Amines; Analgesics, Opioid; Anticonvulsants; Cyclohexanecarboxylic Acids; Gabapentin; gamm | 2001 |
Gamma-aminobutyric acid and the search for new anticonvulsant drugs.
Topics: 4-Aminobutyrate Transaminase; Aldehyde Oxidoreductases; Aminobutyrates; Animals; Anticonvulsants; Ba | 1978 |
Focal contralateral myoclonus produced by inhibition of GABA action in the caudate nucleus of rats.
Topics: Aminobutyrates; Animals; Carnitine; Caudate Nucleus; Corpus Striatum; Electrophysiology; Female; Fun | 1978 |
Focal myoclonus produced by injection of picrotoxin into the caudate nucleus of the rat.
Topics: Animals; Caudate Nucleus; gamma-Aminobutyric Acid; Myoclonus; Picrotoxin; Rats | 1975 |
Neurophysiology of photically induced epilepsy in Papio papio.
Topics: Aluminum; Animals; Cerebral Cortex; Cobalt; Corpus Callosum; Disease Models, Animal; Epilepsy; Evoke | 1975 |
Drugs influencing the GABAergic neurotransmission have no effect on the non-epileptic myoclonus of baboons.
Topics: Animals; Anticonvulsants; Benzodiazepines; Clonazepam; Female; gamma-Aminobutyric Acid; Male; Myoclo | 1991 |
A functional interaction between GABA and 5-HT in inhibiting picrotoxin-induced myoclonus in rats.
Topics: 5-Hydroxytryptophan; Aminooxyacetic Acid; Animals; Fenclonine; gamma-Aminobutyric Acid; Male; Myoclo | 1990 |
Increased gamma-aminobutyric acid receptor function in the cerebral cortex of myoclonic calves with an hereditary deficit in glycine/strychnine receptors.
Topics: Animals; Benzodiazepines; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cattle | 1990 |
Biochemistry and therapeutics of posthypoxic myoclonus.
Topics: 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Aspartic Acid; Benzodiazepines; Carbidopa; Electro | 1986 |
Possible mechanisms of action of valproic acid in myoclonus.
Topics: 4-Aminobutyrate Transaminase; 5-Hydroxytryptophan; Animals; Brain; gamma-Aminobutyric Acid; Glycine; | 1986 |
Urea myoclonus: possible involvement of glycine.
Topics: Animals; gamma-Aminobutyric Acid; Glycine; Male; Myoclonus; Rats; Rats, Inbred Strains; Receptors, G | 1986 |
Gamma-aminobutyric acid and the high pressure neurological syndrome.
Topics: Alanine; Aminobutyrates; Animals; Atmospheric Pressure; Central Nervous System Diseases; Electrodes, | 1986 |
Experimental study on central effects of carboxyethyl-gamma-aminobutyric acid (CEGABA).
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain; Disease Models, Animal; Electroencephalograph | 1988 |
Progabide in the treatment of hyperkinetic extrapyramidal movement disorders.
Topics: Adolescent; Adult; Aged; Athetosis; Basal Ganglia Diseases; Child; Chorea; Female; gamma-Aminobutyri | 1985 |
Animal models of myoclonus using 1,2-dihydroxybenzene (catechol) and chloralose.
Topics: Acetylcholine; Animals; Brain; Catecholamines; Catechols; Chemical Phenomena; Chemistry; Chloralose; | 1986 |
Myoclonus induced by intermittent light stimulation in the baboon: neurophysiological and neuropharmacological approaches.
Topics: 4-Aminobutyrate Transaminase; Amino Acids; Animals; Anticonvulsants; Apomorphine; Bromocriptine; Cer | 1986 |
Coping and seizure susceptibility: control over shock protects against bicuculline-induced seizures.
Topics: Adaptation, Psychological; Animals; Bicuculline; Electroshock; Escape Reaction; gamma-Aminobutyric A | 1985 |
[Syndrome involving the extrapyramidal motor systems and their drug treatment].
Topics: Amantadine; Antiparkinson Agents; Basal Ganglia Diseases; Dihydroxyphenylalanine; gamma-Aminobutyric | 1974 |